Published in Anal Biochem on July 15, 2002
Single sample extraction protocol for the quantification of NAD and NADH redox states in Saccharomyces cerevisiae. J Sep Sci (2008) 1.09
Stable isotope labeling by essential nutrients in cell culture for preparation of labeled coenzyme A and its thioesters. Anal Chem (2011) 1.08
Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1. Proc Natl Acad Sci U S A (2013) 1.00
Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Exp Hematol (2009) 0.93
Light suppresses melatonin secretion in humans. Science (1980) 3.45
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A (1983) 3.39
Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci U S A (2003) 2.70
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol (2005) 2.39
Glutaric aciduria; a "new" disorder of amino acid metabolism. Biochem Med (1975) 1.91
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature (1984) 1.50
2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology (1990) 1.40
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man. Can J Neurol Sci (1984) 1.36
Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy. Exp Neurol (2008) 1.33
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J (1996) 1.32
Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J Neuroimmunol (2001) 1.31
Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience (1991) 1.23
Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J (1998) 1.23
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience (1992) 1.22
Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol (1992) 1.22
Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J (1992) 1.21
MPTP toxicity: implications for research in Parkinson's disease. Annu Rev Neurosci (1988) 1.16
A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J Biol Chem (1993) 1.15
Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J (1992) 1.14
Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann Neurol (1989) 1.10
Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem (1987) 1.09
Characterization of branched monounsaturated hydrocarbons of Sarcina lutea and Sarcina flava. Lipids (1971) 1.08
Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J Neurochem (1993) 1.07
Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry. Biomed Mass Spectrom (1981) 1.06
Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J Neurochem (1993) 1.05
Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid. Brain Res (1992) 1.04
Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Res (1991) 1.01
The role of lactic acid in autocrine B-cell growth stimulation. Proc Natl Acad Sci U S A (1991) 1.00
Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy. Intensive Care Med (2004) 0.99
Lesions of the paraventricular nucleus area of the hypothalamus disrupt the suprachiasmatic leads to spinal cord circuit in the melatonin rhythm generating system. Brain Res Bull (1983) 0.98
Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation. Brain (1998) 0.98
2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat. J Pharmacol Exp Ther (1991) 0.98
Identification of methoxyester artifacts produced by methanolic-HCI solvolysis of the cyclopropane fatty acids of the genus Yersinia. Biochim Biophys Acta (1974) 0.96
Nonpolar lipid methylation. Biosynthesis of fatty acid methyl esters by rat lung membranes using S-adenosylmethionine. J Biol Chem (1981) 0.96
4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells). Biochem J (1993) 0.96
Quantitative metabolic profiling of urinary organic acids by gas chromatography-mass spectrometry: comparison of isolation methods. Anal Chem (1975) 0.95
Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem (2002) 0.93
Diagnosis of organic acidemias by gas chromatography--mass spectrometry. Lab Res Methods Biol Med (1981) 0.93
2-Amino-3 (methylamino)-propionic acid in cycad-derived foods is an unlikely cause of amyotrophic lateral sclerosis/parkinsonism. Lancet (1988) 0.92
Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects. Life Sci (1985) 0.92
Analysis of melatonin in human plasma by gas chromatography negative chemical ionization mass spectrometry. Science (1978) 0.90
Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey. Psychopharmacol Bull (1984) 0.90
Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis (1993) 0.89
Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur J Pharmacol (1984) 0.89
Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci (1985) 0.89
Kynurenine 3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia. Arch Biochem Biophys (1993) 0.88
Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J Neuropsychiatry Clin Neurosci (1992) 0.87
Dihydrocaffeic acid: a common contaminant in the liquid chromatographic-electrochemical measurement of plasma catecholamines in man. J Chromatogr (1984) 0.87
Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. J Neurochem (1997) 0.87
(18O)quinolinic acid: its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acid. Biomed Environ Mass Spectrom (1988) 0.87
Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG. Adv Biochem Psychopharmacol (1984) 0.86
Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res (1989) 0.86
Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxia. Transl Stroke Res (2012) 0.86
Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-D. Brain Res (1990) 0.86
Quantification of the putative neurotoxin 2-amino-3-(methylamino)propanoic acid (BMAA) in cycadales: analysis of the seeds of some members of the family Cycadaceae. J Anal Toxicol (1990) 0.86
Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional guamanian methods. J Neurosci (1992) 0.85
Parkinsonism induced by solvent abuse. Ann Neurol (1994) 0.84
Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG. Arch Gen Psychiatry (1980) 0.83
Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. Arch Gen Psychiatry (1988) 0.83
Gbetagamma affinity for bovine rhodopsin is determined by the carboxyl-terminal sequences of the gamma subunit. J Biol Chem (2001) 0.83
1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent. Life Sci (1986) 0.83
Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques. Brain Res (1991) 0.83
Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading. FEBS Lett (1989) 0.83
The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin Chim Acta (1985) 0.83
Assessment of the macrophage marker quinolinic acid in cerebrospinal fluid after pediatric traumatic brain injury: insight into the timing and severity of injury in child abuse. J Neurotrauma (2004) 0.82
GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. J Neurochem (1999) 0.82
Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures. Epilepsia (1990) 0.82
Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies. Clin Chem (2002) 0.82
Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism. Arch Gen Psychiatry (1978) 0.82
Facile oxidative decarboxylation of 3,4-dihydroxyphenylacetic acid catalyzed by copper and manganese ions. Biochim Biophys Acta (1996) 0.82
Proteomic analysis of nuclei dissected from fixed rat brain tissue using expression microdissection. Anal Chem (2013) 0.81
2-Amino-3-(methylamino)propanoic acid (BMAA) bioavailability in the primate. Neurobiol Aging (1992) 0.81
Stimulation of the paraventricular nucleus area of the hypothalamus elevates urinary 6-hydroxymelatonin during daytime. Brain Res Bull (1987) 0.81
DNA strand breakage, thymine glycol production, and hydroxyl radical generation induced by different samples of crystalline silica in vitro. Environ Res (1995) 0.81
Disposition and metabolism of MHPG in humans: application to studies in depression. Pharmacopsychiatry (1984) 0.81
Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease. Neurosci Lett (1991) 0.81
4-chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury. J Neurotrauma (2006) 0.80
Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. J Neurochem (1995) 0.80
Pentafluorobenzyl chloroformate derivatization for enhancement of detection of amino acids or alcohols by electron capture negative ion chemical ionization mass spectrometry. J Am Soc Mass Spectrom (1995) 0.80
Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Adv Exp Med Biol (1991) 0.80
Conjugated 3,4 dihydroxy phenyl acetic acid (DOPAC) in human and monkey cerebrospinal fluid and rat brain and the effects of probenecid treatment. Life Sci (1976) 0.80
Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading. Brain Res (1989) 0.80
6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation. Neurosci Lett (1994) 0.80
Gas-chromatographic/mass-spectrometric identification and quantitation of tetronic and deoxytetronic acids in urine from normal adults and neonates. Clin Chem (1975) 0.80
Acidic components of green river shale identified by a gas chromatography-mass spectrometry-computer system. Science (1969) 0.79
Clonidine reduces plasma melatonin levels. J Pharm Pharmacol (1986) 0.79
L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish. Eur J Pharmacol (1993) 0.78
Nonpolar lipid methylation-identification of nonpolar methylated products synthesized by rat basophilic leukemia cells, retina and parotid. Biochem Pharmacol (1982) 0.78
Purification and identification of pituitary cytotropic factor. Proc Natl Acad Sci U S A (1995) 0.78
Pentafluorobenzylation method for quantification of acidic tryptophan metabolites using electron capture negative ion mass spectrometry. Anal Chem (1995) 0.78
Distribution and excretion in the rat and monkey of [82Br] bromocriptine. J Pharmacol Exp Ther (1979) 0.78
Cytokine and drug modulation of kynurenine pathway metabolism by blood mononuclear cells. Adv Exp Med Biol (1996) 0.78
Reduced paraquat does not exhibit MPTP-like neurotoxicity. J Anal Toxicol (1987) 0.78
Pinealectomy abolishes plasma melatonin in the rat. J Clin Endocrinol Metab (1980) 0.77
Measurement of 6-hydroxymelatonin in human urine and its diurnal variations. Life Sci (1980) 0.77
The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds. Med Res Rev (1986) 0.77